HUL Q2FY27: Profit Up 4% on 15% Sales Growth, But Margin Slips 140 bps

Inside HUL's September Quarter: Record Sales Growth, Thinner Margins

Hindustan Unilever closed the September 2026 quarter with consolidated net profit attributable to owners of ₹2,790 crore, up 3.9 per cent from ₹2,685 crore a year earlier. The headline comparison was flattered by a ₹97 crore loss from discontinued operations in the year-ago period: on a continuing-operations basis, profit was essentially flat at ₹2,796 crore. Strip out exceptional items and profit after tax rose 9.5 per cent to ₹2,795 crore.

The top line was the stronger story. Turnover rose 14.8 per cent to ₹18,071 crore, and underlying sales growth of 15 per cent was HUL's best in 14 quarters, supported by 7 per cent underlying volume growth. That combination — more product sold, at higher value — is what the company has been chasing through portfolio and channel changes.

Profitability did not keep pace. Total expenses rose 15.9 per cent to ₹14,574 crore, and Ebitda margin contracted 140 basis points to 22.6 per cent even as Ebitda itself grew 8 per cent to ₹4,089 crore. The segment split explains much of the squeeze: Home Care revenue jumped 21.4 per cent to ₹6,878 crore but segment profit rose only 2.6 per cent, while Personal Care revenue grew 7.9 per cent and segment profit fell 8.7 per cent. Beauty and Wellbeing and Foods both delivered healthier profit conversion.

The board declared an interim dividend of ₹19 per equity share, with a record date of November 12 and payment on November 25. Management described demand conditions as resilient, said it expects FY27 to be better than FY26, and maintained its consolidated Ebitda margin guidance of 22–24 per cent while flagging commodity inflation in the near term.

Why HUL's Home Care Boom Is Also Its Margin Problem

Home Care's Growth Is Costing More Than It Earns

Home Care was the quarter's engine — 22 per cent underlying sales growth, double-digit volume growth, revenue up 21.4 per cent to ₹6,878 crore. Yet segment profit rose just 2.6 per cent to ₹1,111 crore. That gap is the single most important number in this release: it implies the segment's margin fell sharply, most plausibly because the input costs tied to detergents and household care — commodity and packaging-linked — rose faster than HUL could recover through price or mix. The company's own guidance of near-term commodity inflation is consistent with that reading, though the article does not break out the specific cost drivers.

Personal Care Is the Bigger Worry

Personal Care is the only segment where profit actually fell — down 8.7 per cent to ₹449 crore on 7.9 per cent revenue growth, with flat underlying volume growth. Flat volumes in a segment that includes skin cleansing and hair care suggests HUL is neither winning new users nor raising prices enough to offset costs. For a business that has historically been HUL's profit engine, this is a competitive signal as much as a cost signal: rivals in mass personal care have been aggressive on price and on regional and digital-first brands.

Beauty and Foods Are Carrying the Mix

Beauty and Wellbeing grew revenue 15.7 per cent and segment profit 16.4 per cent — profit outgrowing revenue — while Foods grew revenue 8.5 per cent and segment profit 15.7 per cent. These two segments are doing the work of protecting group margin. The strategic read: HUL's premiumisation push is working where it has been applied hardest, and the drag is concentrated in the mass, commodity-linked end of the portfolio.

What the 22–24% Guidance Really Commits HUL To

At 22.6 per cent, HUL is sitting just inside the bottom half of its maintained 22–24 per cent band. Holding that band through commodity inflation while Home Care grows at 20%-plus requires either price increases, a richer mix, or cost savings — the article does not specify which levers management intends to pull. For context, a 140 basis point margin decline on ₹18,226 crore of quarterly revenue is roughly ₹255 crore of profit that did not materialise relative to last year's margin rate; recovering it is the central task of the next two to three quarters.

Where This Leaves Competitors and the Street

A 15 per cent underlying sales growth print is a strong demand signal for the Indian FMCG category, and it raises the bar for peers reporting later in the season. But the margin compression shows that volume-led growth in mass categories is currently expensive to buy. Investors will likely weigh the dividend and the reaffirmed guidance against the fact that profit growth (3.9 per cent reported) lagged sales growth (14.8 per cent) by a wide margin — a divergence that typically invites questions about pricing power.

What HUL's Q2 Numbers Mean for Investors and Competitors

HUL's September quarter shows the classic FMCG trade-off in its sharpest form: the company bought its best sales growth in 14 quarters with margin, and the question now is whether that was a deliberate investment or a cost problem.

• For investors: Reported profit growth of 3.9% versus 14.8% turnover growth means the earnings quality debate is live. Track whether the 22.6% Ebitda margin moves back toward the middle of the 22–24% band in the December quarter — that is the clearest test of whether Home Care's cost pressure is transient.
• For competitors in Home Care and Personal Care: HUL is defending volume aggressively even at the cost of segment profit. Expect continued price and promotion intensity in detergents and mass personal care, where HUL's Personal Care volumes were flat and profit fell 8.7%.
• For income-focused holders: The ₹19 interim dividend with a November 12 record date and November 25 payment is the near-term cash event; the reaffirmed 22–24% margin guidance is the medium-term anchor.
• Watch next: the December-quarter print for (1) Home Care segment profit growth versus its 22% sales growth, (2) whether Personal Care volumes return to growth, and (3) any commentary on the specific commodities management flagged as inflationary.